These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36839865)

  • 1. Metabolomics Profiling Reveals the Role of PEDF in Triple-Negative Breast Cancer Cell MDA-MB-231 under Glycaemic Loading.
    Abooshahab R; Hooshmand K; Luna G; Al-Salami H; Dass CR
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Pigment-Epithelium-Derived Factor on MCF-7 Cell Metabolism in the Context of Glycaemic Condition.
    Abooshahab R; Hooshmand K; Salami HA; Dass CR
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between PEDF and Doxorubicin in Breast Cancer Cells: Effects on Metastatic and Metabolic Pathways.
    Abooshahab R; Al-Salami H; Dass CR
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.
    Coleman MF; O'Flanagan CH; Pfeil AJ; Chen X; Pearce JB; Sumner S; Krupenko SA; Hursting SD
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell metabolomics to study the function mechanism of Cyperus rotundus L. on triple-negative breast cancer cells.
    Ma S; Wang F; Zhang C; Wang X; Wang X; Yu Z
    BMC Complement Med Ther; 2020 Aug; 20(1):262. PubMed ID: 32843016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles.
    Wojtowicz W; Wróbel A; Pyziak K; Tarkowski R; Balcerzak A; Bębenek M; Młynarz P
    Metabolites; 2020 Apr; 10(5):. PubMed ID: 32349447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.
    Lanning NJ; Castle JP; Singh SJ; Leon AN; Tovar EA; Sanghera A; MacKeigan JP; Filipp FV; Graveel CR
    Cancer Metab; 2017; 5():6. PubMed ID: 28852500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted and stable isotope-assisted metabolomic analysis of MDA-MB-231 cells under hypoxia.
    Yang J; Cheng J; Sun B; Li H; Wu S; Dong F; Yan X
    Metabolomics; 2018 Feb; 14(4):40. PubMed ID: 30830323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GC-MS based comparative metabolomic analysis of MCF-7 and MDA-MB-231 cancer cells treated with Tamoxifen and/or Paclitaxel.
    Semreen MH; Alniss H; Cacciatore S; El-Awady R; Mousa M; Almehdi AM; El-Huneidi W; Zerbini L; Soares NC
    J Proteomics; 2020 Aug; 225():103875. PubMed ID: 32534214
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    AlMalki RH; Sebaa R; Al-Ansari MM; Al-Alwan M; Alwehaibi MA; Rahman AMA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids.
    Guerra ÂR; Paulino AF; Castro MM; Oliveira H; Duarte MF; Duarte IF
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells.
    Rushing BR; Molina S; Sumner S
    Metabolites; 2023 Jul; 13(7):. PubMed ID: 37512572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.
    Stewart DA; Winnike JH; McRitchie SL; Clark RF; Pathmasiri WW; Sumner SJ
    J Proteome Res; 2016 Sep; 15(9):3225-40. PubMed ID: 27447733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells.
    Xue L; Wu M; Li Y; Chen S; Wu M; Zhu J; Ding S; Zhang Q; Zheng C; He G; Fu S; Li G; Deng X
    J Cancer; 2022; 13(12):3368-3377. PubMed ID: 36186902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis.
    Alosaimi ME; Alotaibi BS; Abduljabbar MH; Alnemari RM; Almalki AH; Serag A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jun; 1240():124144. PubMed ID: 38703714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cells.
    Borrego SL; Fahrmann J; Datta R; Stringari C; Grapov D; Zeller M; Chen Y; Wang P; Baldi P; Gratton E; Fiehn O; Kaiser P
    Cancer Metab; 2016; 4():9. PubMed ID: 27141305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and lipidomic characterization of radioresistant MDA-MB-231 human breast cancer cells to investigate potential therapeutic targets.
    Lee H; To NB; Kim M; Nguyen YT; Cho SK; Choi HK
    J Pharm Biomed Anal; 2022 Jan; 208():114449. PubMed ID: 34749107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFκB-Mediated Mechanisms Drive PEDF Expression and Function in Pre- and Post-Menopausal Oestrogen Levels in Breast Cancer.
    Brook N; Gill J; Dharmarajan A; Chan A; Dass CR
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted metabolomics reveals dynamic portrayal of amino acids and derivatives in triple-negative breast cancer cells and culture media.
    Kou F; Zhu B; Zhou W; Lv C; Cheng Y; Wei H
    Mol Omics; 2021 Feb; 17(1):142-152. PubMed ID: 33295912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin.
    Hong H; Zhou T; Fang S; Jia M; Xu Z; Dai Z; Li C; Li S; Li L; Zhang T; Qi W; Bardeesi AS; Yang Z; Cai W; Yang X; Gao G
    Breast Cancer Res Treat; 2014 Nov; 148(1):61-72. PubMed ID: 25284724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.